Skip to main content

Table 2 Baseline characteristics stratified by mortality and survival of patients with a certified outcome in Mashhad City from Feb 14, to May 11, 2020

From: Epidemiological characteristics and initial spatiotemporal visualisation of COVID-19 in a major city in the Middle East

Reference

All patients

Non-survivors

Survivors

p-value

Number of patients (%)

2943 (100)

707 (24)

2236 (76)

 

Median age of the patients

57.0

68.0

52.0

0.0001*

Age range

40.0–71.0

59.0–79.0

36.0–66.0

Days from onset to hospital admission

2.0

2.0

2.0

0.0695

Range of days

1.0–4.0

0.0–4.0

1.0–4.0

Days from hospital admission to outcome

5.0

6.0

4.0

< 0.0001*

Range of days

2.0–8.0

2.0–10.0

2.0–7.0

Demographics & Clinical Characteristics

Number (%)

Number (%)

Number (%)

 

Sex

…

…

…

0.5832

 Female

1179 (40.06)

277 (39.18)

902 (40.34)

…

 Male

1764 (59.94)

430 (60.82)

1334 (59.66)

…

Co-morbidity

 Diabetes

405 (13.76)

129 (18.25)

276 (12.34)

0.0001*

 CVD

614 (20.86)

197 (27.86)

417 (18.64)

< 0.0001*

 Liver disorders

89 (3.02)

28 (3.96)

61 (2.72)

0.0953

 CRD

120 (4.07)

38 (5.37)

82 (3.67)

0.0453*

 Nervous diseases

69 (2.34)

28 (3.96)

41(1.83)

0.0011*

 COPD

181 (6.15)

71 (10.04)

110 (4.91)

< 0.0001*

 Malignancy (any)

73 (2.48)

39 (5.51)

34 (1.52)

< 0.0001*

Initial symptoms

 Fever

1720 (58.44)

385 (54.45)

1335 (59.70)

0.0135*

 Cough

1874 (63.67)

378 (53.46)

1496 (66.90)

< 0.0001*

 Dyspnoea

2111 (71.72)

579 (81.90)

1532 (68.51)

< 0.0001*

 Weakness

533 (18.11)

122 (17.25)

411 (18.38)

0.4984

 Myalgia

429 (14.57)

71 (10.04)

358 (16.01)

< 0.0001*

 Dizziness

247 (8.39)

80 (11.31)

167 (7.47)

0.0013*

 Sore throat

352 (11.96)

47 (6.64)

305 (13.64)

< 0.0001*

 Sputum

55 (1.86)

5 (0.70)

50 (2.23)

0.0088*

 Diarrhoea

101 (3.43)

16 (2.26)

85 (3.80)

0.0501

 Nausea or vomiting

246 (8.36)

39 (5.51)

207 (9.26)

0.0017*

 Headache

245 (8.32)

35 (4.95)

210 (9.39)

0.0001*

 Chest pain

223 (7.57)

49 (6.93)

174 (7.78)

0.2906

 Abdominal pain

39 (1.32)

3 (0.42)

36 (1.61)

0.0162*

 Arthralgia

176 (5.98)

25 (3.53)

151 (6.75)

0.0016*

 Pharyngitis

37 (1.25)

6 (0.85)

31 (0.14)

0.2633

 Conjunctivitis

18 (0.61)

2 (0.28)

15 (0.72)

0.1984

 Seizure

22 (0.75)

6 (0.85)

16 (0.71)

0.7203

Abnormal chest X-ray

697 (23.68)

186 (26.30)

511 (22.85)

0.0596

 End-points

 ICU admission

338 (11.48)

150 (21.21)

188 (8.40)

< 0.0001*

 Ventilator

549 (18.65)

209 (29.56)

340 (15.20)

< 0.0001*

 Coma

19 (0.65)

9 (1.27)

10 (0.45)

0.0168*

Disease severity status

…

…

…

0.0033*

 General

2418 (82.16)

551 (77.93)

1867 (83.50)

…

 Severe

503 (17.09)

150 (21.22)

353 (15.78)

…

 Critical

22 (0.75)

6 (0.85)

16 (0.72)

…

  1. CVD Cardiovascular Diseases, CRD Chronic Renal Diseases, COPD Chronic Obstructive Pulmonary Diseases, ICU Intensive Care Unit. *Significant values